TVTX vs COGT
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
TVTX · Travere Therapeutic$49.60 ▲ 1.49%
COGT · Cogent Biosciences$31.65 ▲ 6.98%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- TVTX +44.3%
- COGT -2.5%
Head to head
| Metric | TVTX | COGT |
|---|---|---|
| Price | $49.60 | $31.65 |
| Change today | ▲ 1.49% | ▲ 6.98% |
| Market cap | $4.76B | $5.49B |
| Return, 3 months | -18.5% | -23.8% |
| Return, year to date | +29.8% | -10.9% |
| Return, 1 year | +53.4% | +113.5% |
| P/E (TTM) | -38.2 | -14.7 |
| P/B | 211.1 | 11.7 |
| P/E percentile vs own 5y | 11th | 18th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +48.2% | – |
| Net profit growth (YoY) | -172.8% | -31.1% |
| Gross margin | 97.6% | – |
| Operating margin | -6.8% | – |
| Net margin | -7.4% | – |
| Return on equity | -151.8% | -146.5% |
| Analyst target vs. price | +53.1% | +73.4% |
| Analyst buy share | 92% | 89% |
| RSI (14) | 40 | 52 |
| 30-day volatility | 46.0% | 47.6% |
| Max drawdown, 1 year | -33.5% | -34.4% |
| Trend read | Leaning bearish | Leaning bullish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- COGT is the largest of the group by market value.
- COGT has returned the most over the past year.
- TVTX carries the lowest trailing P/E.
- TVTX has been the calmest stock over the last 30 days.